Marion Biotech stops production of cough syrup linked to death of 18 kids in Uzbekistan

Published On 2022-12-29 11:39 GMT   |   Update On 2022-12-29 11:39 GMT
Advertisement

A team of central agencies and the Uttar Pradesh drug department on Thursday carried out an inspection at the Noida office of a pharmaceutical firm whose cough syrup is allegedly linked to the death of 18 children in Uzbekistan, officials said.

The company, Marion Biotech, does not sell the cough syrup, 'Doc-1 Max', in India and its only export has been to Uzbekistan, a state government official said.

For more details, check out the full story on the link below:

Marion Biotech Stops Production Of Cough Syrup Linked To Death Of 18 Kids In Uzbekistan, CDSCO Initiates Probe


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News